Founded in 2016, Qrons is a publicly traded, preclinical biotechnology company, developing advanced cell-based solutions to combat neurological injuries. While we are laser-focused on traumatic brain injury (TBI), our technology could potentially treat a wide range of neurodegenerative diseases.
Our TBI treatment integrates proprietary, engineered mesenchymal stem cells (MSCs), 3D printable scaffolding, smart materials and a novel delivery system.
We believe this combination will reduce neuronal loss and functional impairment and possibly regenerate brain tissue and function for TBI patients.
Our Multidisciplinary Team
TBI presents many complex challenges. To overcome these, Qrons has developed a coordinated group of product-oriented research teams.
Each team leverages different skill sets to tackle different challenges. This multidisciplinary approach is designed to produce a revolutionary TBI treatment.
Qrons’ co-founders, Jonah Meer and Ido Merfeld, believe it’s time to upend the traditional approach to developing new treatments. The two have a long history of bringing disruptive ideas into well-established sectors. Their collaborative mindset fuels Qrons’ efforts to solve TBI and other neuronal conditions.
By combining stellar scientists with innovative business people, Qrons is redesigning how scientific teams come together to find solutions. This unique approach seeks to create the best possible treatments in the least possible time.
The Qrons Logo
Our logo reflects the character of the company’s unique and original approach to business and research.
The “Q” in our name represents “questioning”—one way Qrons is changing the way research is translated into products. The logo mark is a graphic representation of a functional neuron, signifying our corporate mission to fight neuronal conditions.
Management Team and Board of Directors
Co-founder, Chief Executive Officer, Chief Financial Officer, Secretary, Director
Jonah Meer is an attorney, accountant and entrepreneur who has worked for decades in the financial services and investment industries. Since 1998, he has been CEO of jTrade Global …
Co-founder, President, Director
In 1991, Ido Merfeld co-founded Ivory Software Systems, which supports the financial services industry in Israel and abroad. In 1998, he co-founded jTrade Global LLC., a U.S. company that provides financial products and services in the U.S. …
Dr. Baranes heads the Department of Molecular Biology at Ariel University. He conducted his postdoctoral fellowship in neuroscience with Nobel laureate Eric Kandel at Columbia University. Dr. Baranes held several positions …
Dr. Liat Hammer runs Qrons’ research and development efforts. Prior to this, Dr. Hammer was a lab manager at Ariel University, engineering brain, heart and liver tissue. In addition, Dr. Hammer spent six years as a senior …
Yitshak “Itsik” Francis
Dr. Yitshak Francis is director of business development at Ariel Scientific Innovations, Ariel University’s technology transfer company, and is Ariel’s board observer. Dr. Francis received his biology degree …
Dr. Albert Pinhasov is Vice-President and Dean for Research and Development at Ariel University. He is a molecular biologist specializing in the neurobiology of social behavior. In addition, Dr. Pinhasov was a …
Dr. Motti Ratmansky is the head of the Pain Rehabilitation Clinic at the Lowenstein Rehabilitation Hospital in Israel. He was the former head of the Israeli National Instruction Unit for combat medics and medical …
Board of Directors